Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population Seroprevalence

Table 2

VZV, EBV, and CMV seroprevalence.

	VZV ()	EBV ()	CMV ()
Seroprevalence	97.6% ()	86.5% ()	30% ()
<60 years	98% ()	84% ()	25.75% ()
>60 years	94% ()	100% ()	50% ()